These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9844038)

  • 1. Vaccination against meningococcus in complement-deficient individuals.
    Morgan BP; Orren A
    Clin Exp Immunol; 1998 Dec; 114(3):327-9. PubMed ID: 9844038
    [No Abstract]   [Full Text] [Related]  

  • 2. Meningococcal vaccines.
    Poolman JT
    J Med Microbiol; 1988 Jul; 26(3):170-2. PubMed ID: 3134548
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.
    Fijen CA; Kuijper EJ; Drogari-Apiranthitou M; Van Leeuwen Y; Daha MR; Dankert J
    Clin Exp Immunol; 1998 Dec; 114(3):362-9. PubMed ID: 9844044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of complement in anti-bacterial defence.
    D'Amelio R; Biselli R
    Ann Ital Med Int; 1994; 9(3):173-7. PubMed ID: 7946895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The last of the meningococcus?
    Segal S; Pollard AJ
    Adv Exp Med Biol; 2004; 549():201-9. PubMed ID: 15250534
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunoprophylaxis of meningococcal infection among the troops].
    Khokhlov DT; Efimov EI
    Voen Med Zh; 1984 Oct; (10):51-3. PubMed ID: 6438904
    [No Abstract]   [Full Text] [Related]  

  • 7. Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine?
    MacDonald NE; Halperin SA; Law BJ; Danzig LE; Granoff DM
    JAMA; 2000 Apr; 283(14):1826-7. PubMed ID: 10770143
    [No Abstract]   [Full Text] [Related]  

  • 8. Meningococcal Serogroup A, B, C, W, X, and Y Serum Bactericidal Antibody Assays.
    Lucidarme J; Louth J; Townsend-Payne K; Borrow R
    Methods Mol Biol; 2019; 1969():169-179. PubMed ID: 30877677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines Against Meningococcus - An update of the progresses in meningitis prevention. Proceeding of the Meningococcus Scientific Exchange Meeting. Siena, Italy. July 1-3, 2008.
    Vaccine; 2009 Jun; 27 Suppl 2():B1-125. PubMed ID: 19771612
    [No Abstract]   [Full Text] [Related]  

  • 10. Phagocytic killing and antibody response during the first year after tetravalent meningococcal vaccine in complement-deficient and in normal individuals.
    Schlesinger M; Kayhty H; Levy R; Bibi C; Meydan N; Levy J
    J Clin Immunol; 2000 Jan; 20(1):46-53. PubMed ID: 10798607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meningococcus infection: problem actuality].
    Tereshchuk TO; Chugriiev AM
    Lik Sprava; 2011; (3-4):41-4. PubMed ID: 22416362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. For discussion: live attenuated vaccines for group B meningococcus.
    Tang C; Moxon R; Levine MM
    Vaccine; 1999 Jan; 17(2):114-7. PubMed ID: 9987144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine.
    Platonov AE; Beloborodov VB; Pavlova LI; Vershinina IV; Käyhty H
    Clin Exp Immunol; 1995 Apr; 100(1):32-9. PubMed ID: 7697919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against meningococcal disease.
    Griffiss JM
    N Engl J Med; 1983 Jun; 308(23):1421. PubMed ID: 6405276
    [No Abstract]   [Full Text] [Related]  

  • 15. Indirect effects by meningococcal vaccines: herd protection versus herd immunity.
    Bröker M
    Hum Vaccin; 2011 Aug; 7(8):881-2. PubMed ID: 21785283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous bacterial peritonitis due to Neisseria meningitidis serogroup Z.
    Nathanson L
    Clin Pediatr (Phila); 1993 Aug; 32(8):510. PubMed ID: 8257548
    [No Abstract]   [Full Text] [Related]  

  • 17. Further conquest of the meningococcus.
    Lepow ML; Gold R
    N Engl J Med; 1977 Sep; 297(13):721-2. PubMed ID: 408684
    [No Abstract]   [Full Text] [Related]  

  • 18. Meningococcal vaccine group C conjugate (Wyeth-Lederle).
    Drugs R D; 1999 Sep; 2(3):213-4. PubMed ID: 10641232
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunoprophylaxis problem in meningococcal infection].
    Efimov DD; Belova TN
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Jul; (7):23-9. PubMed ID: 89767
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of invasive serogroup C meningococcal disease after a community vaccination programme in Rotherham, South Yorkshire.
    Irwin DJ; Kaczmarski EB; Miller JM
    J Public Health Med; 1998 Mar; 20(1):112-4. PubMed ID: 9602462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.